These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 1790309)

  • 1. Factors influencing the protein binding of vancomycin.
    Shin WG; Lee MG; Lee MH; Kim ND
    Biopharm Drug Dispos; 1991 Dec; 12(9):637-46. PubMed ID: 1790309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors influencing the protein binding of YH-439 using an equilibrium dialysis technique. A new hepatoprotective agent.
    Lee WI; Yoon WH; Park JH; Lee JW; Shim CK; Lee MG
    Biopharm Drug Dispos; 1995 Dec; 16(9):775-89. PubMed ID: 8580401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors influencing the protein binding of bumetanide using an equilibrium dialysis technique.
    Shim HJ; Lee MG; Lee MH
    J Clin Pharm Ther; 1991 Dec; 16(6):467-76. PubMed ID: 1770075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the protein binding of IQO4, a new isoquinolinedione derivative.
    Moon YJ; Kim SH; Ryu CK; Lee MG
    Res Commun Mol Pathol Pharmacol; 2000; 108(3-4):167-77. PubMed ID: 11913709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors affecting serum protein binding of cocaine in humans.
    Parker RB; Williams CL; Laizure SC; Lima JJ
    J Pharmacol Exp Ther; 1995 Nov; 275(2):605-10. PubMed ID: 7473145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.
    Shim HJ; Lee EJ; Kim SH; Kim SH; Yoo M; Kwon JW; Kim WB; Lee MG
    Biopharm Drug Dispos; 2000 Oct; 21(7):285-91. PubMed ID: 11512128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between human serum albumin and alpha 1-acid glycoprotein in the binding of lidocaine to purified protein fractions and sera.
    Krauss E; Polnaszek CF; Scheeler DA; Halsall HB; Eckfeldt JH; Holtzman JL
    J Pharmacol Exp Ther; 1986 Dec; 239(3):754-9. PubMed ID: 3795040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buffer and pH effects on propranolol binding by human albumin and alpha 1-acid glycoprotein.
    Ravis WR; Parsons DL; Wang SJ
    J Pharm Pharmacol; 1988 Jul; 40(7):459-63. PubMed ID: 2904983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stability, blood partition, and protein binding of DA-5018, a new nonnarcotic analgesic.
    Shim HJ; Lee JJ; Lee SD; Kim WB; Yang J; Kim SH; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):97-108. PubMed ID: 8824935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors influencing the protein binding of azosemide using an equilibrium dialysis technique.
    Lee SH; Lee MG
    Biopharm Drug Dispos; 1995 Oct; 16(7):615-26. PubMed ID: 8785384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methodologic factors influencing plasma binding of alpha-1-acid glycoprotein-bound and albumin-bound drugs.
    Morse DS; Abernethy DR; Greenblatt DJ
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):535-9. PubMed ID: 3934087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of bupivacaine to human serum proteins, isolated albumin and isolated alpha-1-acid glycoprotein. Differences between the two enantiomers are partly due to cooperativity.
    Mazoit JX; Cao LS; Samii K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):109-15. PubMed ID: 8558418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood partition and protein binding of a new neuroprotective agent for ischemia-reperfusion damage, KR-31378.
    Lee MH; Kim HJ; Kim SH; Kim SO; Lee DH; Lim H; Yoo SE; Lee MG
    Res Commun Mol Pathol Pharmacol; 2001; 110(5-6):361-70. PubMed ID: 12889527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum protein binding of fentanyl. The effect of postoperative acute phase reaction with elevated alpha 1-acid glycoprotein and methodologic problems in determination by equilibrium dialysis].
    Wiesner G; Taeger K; Peter K
    Anaesthesist; 1996 Apr; 45(4):323-9. PubMed ID: 8702049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A; Nishiura T; Ishino M; Yamamoto Y; Ogita I; Kiso Y; Takada K
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of 1-anilino-8-naphthalene sulfonate as a fluorescent probe in the investigation of drug interactions with human alpha-1-acid glycoprotein and serum albumin.
    Essassi D; Zini R; Tillement JP
    J Pharm Sci; 1990 Jan; 79(1):9-13. PubMed ID: 2313585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human albumin and alpha 1-acid glycoprotein binding of propranolol in the presence of a perfluorochemical blood substitute.
    Parsons DL; Shih RL
    Arch Int Pharmacodyn Ther; 1989; 297():294-304. PubMed ID: 2730240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro protein binding behavior of dipyridamole.
    MacGregor TR; Sardi ED
    J Pharm Sci; 1991 Feb; 80(2):119-20. PubMed ID: 2051312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determinants of carbamazepine and carbamazepine 10,11-epoxide binding to serum protein, albumin and alpha 1-acid glycoprotein.
    MacKichan JJ; Zola EM
    Br J Clin Pharmacol; 1984 Oct; 18(4):487-93. PubMed ID: 6487490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors influencing the apparent protein binding of quinidine.
    Guentert TW; Oie S
    J Pharm Sci; 1982 Mar; 71(3):325-8. PubMed ID: 7069591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.